期刊文献+

多囊卵巢综合征的肥胖妇女患有代谢综合征的流行性 被引量:2

Prevalence of metabolic syndrome in obese adolescents with polycystic ovary syndrome
下载PDF
导出
摘要 目的分析多囊卵巢综合征的肥胖妇女患有代谢综合征的流行性和相关特征。方法43例多囊卵巢综合征的肥胖妇女以及31例相匹配的健康肥胖妇女进行系列代谢综合征的检查。结果多囊卵巢综合征的肥胖妇女表现为卵巢体积增大、总睾酮水平和游离雄激素指数增高,血纤溶酶原激活物抑制因子水平升高和糖耐量水平的异常。但两组的腰围、空腹血糖、血压和血脂无显著性差异。26%的多囊卵巢综合征的肥胖妇女和29%的对照组肥胖妇女被诊断为代谢综合征。结论肥胖妇女更容易发生代谢综合症,伴有多囊卵巢综合征的肥胖妇女并不增加发生代谢综合症的发生率。多囊卵巢综合征(PCOS)患者的血纤溶酶原激活物抑制因子含量显著升高,糖耐量异常发生率上升。 Objective To compare the prevalence, and related characteristics of MBS in obese adolescents with and without PCOS. Methods Cross-sectional study of overweight and obese PCOS adults and BMI matched controls: 74 subjects, 43 with PCOS and 31 controls. Physical examination and laboratory evaluation was used for diagnosis of MBS. Results The PCOS group had larger ovarian volume, higher measures of total testosterone and free androgen index than controls, but there were no differences in waist circumference, fasting glucose, blood pressure, or lipids. PCOS adults demonstrated more glucose abnormalities and higher PAI-1. By adult criteria 26% of PCOS and 29% of controls met diagnostic criteria for MBS. Conclusions Obese adolescent women have a high prevalence of MBS, and PCOS does not add additional risk for MBS. PCOS is associated with increased incidence of glucose intol- erance and increased PAl-1.
作者 顾进 祝胜善
出处 《齐齐哈尔医学院学报》 2009年第16期1959-1961,共3页 Journal of Qiqihar Medical University
关键词 代谢综合征(MS) 多囊卵巢综合征 体重指数(BMI) 肥胖 Metabolism syndrome (MS) Polycystic ovary syndrome (PCOS) Obesity
  • 相关文献

参考文献7

  • 1Leibel NI, Baumann EE, Kocherginsky M, et al. 2006 Relationship of adolescent polycystic ovary syndrome to parental metabolic syndrome[J]. J Clin Endocrinnl Metab 91(4) : 1 275-1 283.
  • 2Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. 2004 Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome[J]. Fertil Steril 81(1):19-25.
  • 3Essah PA,Wickham EP, Nestler JE. The metabolic syndrome in polycystie ovary syndrome [J]. Clin Obstet Gynecol 2007, 50 (1) :205-225.
  • 4Coviello AD, Legro RS, Dunaif A. Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance[J]. J Clin Endocrinol Metab 2006, 91(2) :492-497.
  • 5Tarkun l,Canturk Z, Arslan BC,et al. 2004 The plasminogen activator system in young and lean women with polycystic ovary syndrome[J]. Endocr J 51(5) :467-472.
  • 6Tsikouris JP,Suarez JA, Meyerrose GE. 2002 Plasminogen activator inhibitor-1: Physiologic role, regulation, and the influence of common pharmacologic agents. [J]. J Clin Pharmacol 42 (11):1 187-1 199.
  • 7Atiomo WU,Bates SA,Condon JE,et al. 1998 The plasminogen activator system in women with polycystic ovary syndrome[J]. Fertil Steril 69(2):236-241.

同被引文献12

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部